Brain Research through Advancing Innovative Neurotechnologies

Brain Research through Advancing Innovative Neurotechnologies
Name	Brain Research through Advancing Innovative Neurotechnologies
Acronym	BRAIN
Established	2013
Funding	United States federal agencies
Director	Advisory Committee
Country	United States

Contents

Brain Research through Advancing Innovative Neurotechnologies is a United States federal research initiative launched to accelerate development and application of novel neuroscience technologies and tools for mapping, monitoring, and modulating neural circuits. The initiative brings together entities such as the National Institutes of Health, the National Science Foundation, the Defense Advanced Research Projects Agency, the Kavli Foundation, and academic centers including Harvard University, Massachusetts Institute of Technology, and Stanford University to pursue interdisciplinary projects linking basic neuroscience, engineering, and clinical translation. It has influenced funding programs at the European Commission, the Wellcome Trust, and international consortia including the Human Brain Project and collaborations with institutions like the Max Planck Society and the Riken Institute.

Overview and Objectives

The primary objectives align with goals articulated by leaders from the National Institutes of Health, the White House, and policymakers in the U.S. Congress to develop tools for dynamic circuit mapping, high-resolution imaging, and scalable neural modulation, and to translate discoveries to applications in disorders studied at centers such as Mayo Clinic, Johns Hopkins University, and the University of California, San Francisco. The program emphasizes technology platforms inspired by work at laboratories led by investigators associated with Columbia University, California Institute of Technology, Yale University, and University of Oxford, and seeks to catalyze commercialization through partnerships with industry players including Google, IBM, Medtronic, and Boston Scientific. Advisory input has included representatives from philanthropic organizations such as the Chan Zuckerberg Initiative, the Gates Foundation, and the Simons Foundation.

The initiative was proposed in 2013 following policy discussions at the White House and announcements involving the National Institutes of Health director and congressional briefings with members from the United States House Committee on Appropriations, the United States Senate Committee on Health, Education, Labor, and Pensions, and fiscal offices of the United States Department of Health and Human Services. Initial funding combined appropriations directed to the National Institutes of Health, seed investments from the Defense Advanced Research Projects Agency, and matching support from private donors such as the Kavli Foundation and contributions coordinated with the Allen Institute for Brain Science. Subsequent budget allocations involved negotiations with the Office of Management and Budget and oversight by the Government Accountability Office and reporting to committees chaired by figures from the United States Senate and United States House of Representatives.

Research themes include neural circuit mapping using methods developed in laboratories at Harvard University, Massachusetts Institute of Technology, University of California, Berkeley, and University College London, molecular recording approaches inspired by work at the Salk Institute for Biological Studies and Cold Spring Harbor Laboratory, and scalable readout systems influenced by engineering groups at Stanford University and Caltech. Technologies encompass multiphoton imaging techniques advanced in collaborations with groups at Max Planck Institute for Biological Cybernetics and Riken, optogenetic tools originating from work by investigators connected to Stanford University, chemogenetic systems linked to researchers at Yale University, and electrophysiological arrays developed by teams at University of Michigan and Georgia Institute of Technology. Computational frameworks for analysis draw on algorithms and infrastructure from Intel, NVIDIA, Amazon Web Services, and academic centers such as University of Washington and Carnegie Mellon University.

Major projects funded or influenced by the initiative include large-scale mapping efforts at the Allen Institute for Brain Science, the mesoscale connectomics programs at Janelia Research Campus, translational neurotechnology trials at Massachusetts General Hospital and Cleveland Clinic, and international partnerships with the Human Brain Project and consortia involving the European Research Council and the Japan Agency for Medical Research and Development. Collaborative networks link investigators from Princeton University, Columbia University, University of Pennsylvania, and University of Toronto with industry partners such as NeuroPace, Blackrock Neurotech, and Neuropace for device development and clinical trials regulated by the Food and Drug Administration. Cross-disciplinary training and data-sharing initiatives engage programs at Cold Spring Harbor Laboratory, Broad Institute, and the Wellcome Sanger Institute.

Ethical, legal, and social implications have been addressed through working groups convened by the National Institutes of Health, the Presidential Commission for the Study of Bioethical Issues, and international forums including the World Health Organization and the Organisation for Economic Co-operation and Development. Topics explored include privacy and data governance considered by panels linked to Harvard Medical School, consent frameworks developed with input from Georgetown University, dual-use risk assessment discussed at meetings with representatives from the Department of Defense, and regulatory pathways coordinated with the Food and Drug Administration and the European Medicines Agency. Public engagement efforts have involved collaborations with museums and outreach programs at institutions such as the Smithsonian Institution and the American Association for the Advancement of Science.

Scientific achievements attributed to projects fostered by the initiative encompass advances in whole-brain imaging techniques demonstrated by groups at Max Planck Society and Riken, novel optogenetic actuators and genetically encoded indicators introduced from Stanford University and University of California, San Diego, high-density electrophysiology arrays commercialized by companies associated with Blackrock Neurotech and validated in trials at Massachusetts General Hospital, and computational methods for neural data analysis developed at Carnegie Mellon University and University of California, Berkeley. The program has accelerated translational research into neurologic and psychiatric conditions studied at Mayo Clinic, Johns Hopkins University School of Medicine, and Columbia University Irving Medical Center, influenced policy discussions at the White House, and reshaped philanthropic priorities at organizations including the Chan Zuckerberg Initiative and the Kavli Foundation.

Category:Neuroscience programs